Research Ethics Committees identify and correct problems in applications to do cancer trialsAugust 29, 2008Study suggests Research Ethics Committees provide an important independent check on clinical trials Researchers running cancer trials are often critical of the Research Ethics Committee (REC) process they have to go through to get their trials approved, complaining that it's too complex, burdensome and sometimes unreasonable. In the UK only 17% of research study applications are given immediate favourable opinion by RECs. But a new study from the University of Leicester, recently reported in The Lancet Oncology, suggests that RECs may sometimes identify important problems in applications to conduct cancer trials.
The Leicester study, funded by the National Research Ethics Service, looked at 80 anonymised NHS REC decision letters concerning cancer trials, written between March 2004 and December 2006. When reviewing applications to conduct cancer trials, the issue RECs are most likely to raise is that of informed consent. Committees are often concerned that the information that researchers propose to give patients may not be in language that can be easily understood. They also discourage researchers from presenting trials too enthusiastically, and seek to prevent researchers from providing misleading information. One Committee pointed out that the cancer drug side-effects were described as mild on the patient information sheet, but in the investigator's brochure it was noted that several patients had experienced serious adverse events thought to be related to the drug. The study found that RECs identify a high rate of mistakes in applications, including missing information, ticking the wrong boxes, errors in the information provided and not following correct procedures. The findings support the conclusion that RECs, though by their constitution somewhat bureaucratic, provide an important independent check on clinical trials by ensuring that investigators do not omit important information or underestimate risks in the information they give patients. Professor Mary Dixon-Woods, of Medical Sociology in the Department of Health Sciences at the University, commented: "There have been a lot of complaints about REC procedures from researchers in recent years. They often find the process onerous and bureaucratic. However, this study is the first time anyone has systematically analysed what RECs are saying about cancer trial proposals. "RECs are looking for evidence that researchers are sensitive to ethical issues, in particular to participants' interests, and that information given to potential participants explains the trial fully and truthfully. Researchers can improve their chances of success at ethical review by really good preparation." University of Leicester | |||||||||||||||||||||
|
Related Research Ethics Current Events and Research Ethics News Articles Large reservoir of mitochondrial DNA mutations identified in humans Researchers at the University of Newcastle, England, and the Virginia Bioinformatics Institute at Virginia Tech in the United States have revealed a large reservoir of mitochondrial DNA mutations present in the general population. Researchers urge ethics guidelines for human-genome research A global team of legal, scientific and ethics experts have put forward eight key recommendations to establish much needed guidelines for conducting human-genome sequencing research. Toward the ethical treatment of whole genome research participants Recent technological developments have made it possible for scientists to sequence an entire human genome, but these advances may be a mixed blessing. Kennedy Krieger Institute launches first national online autism registry Kennedy Krieger Institute today announced the launch of the Interactive Autism Network (IAN) - the first national online autism registry - at www.IANproject.org. Parents are filled with questions about autism, and, unfortunately, researchers are still struggling with many of the same questions. Lack of Care For Older Breast Cancer Patients Older women with breast cancer get a lower level of care than younger women, researchers at The University of Manchester have found. Therapeutic vaccine for ovarian cancer in clinical trials Prima BioMed (ASX: PRR) announced today at the "Thank You" Day celebration at Sydney Children's Hospital that it has completed initial recruitment of its Phase IIa clinical trial in ovarian cancer at the Austin Hospital. Discussion Paper on ethics of research in developing countries finds problems in practice Applying international guidance on healthcare-related research in developing countries in practice is often fraught with difficulty, according to a Discussion Paper published today by the Nuffield Council on Bioethics. The ethics of research related to healthcare in developing countries: a follow-up Discussion Paper reports that existing guidelines are often inconsistent and inappropriate for the developing country setting. ESC Congress 2004: Brazilian Study suggests intramyocardial injection of cells from bone marrow might be an alternative for heart transplantation in end-stage heart failure due to coronary disease Cardiovascular disease remains the leading cause of morbidity and mortality around the world and patients with end-stage ischemic heart failure carry the highest morbid-mortality rate. Although heart transplant improves the outcomes of selected patients, the donor heart availability has limited its widespread utilization. Autologous bone marrow mononuclear cells transplantation through intramyocardial injections has been used in very initial clinical trials with promising results for treating these patients. The first opportunity to foster partnership between science and society through EU-funded research - don't miss it! Media Alert Until 2 June 2003 the European Commission's invitation for ideas on how to draw closer links between scientists, society and policy makers through EU-funded research is still open for input from individuals and organisations, including the media and the non-government sector. This consultation with Europe's research community and its citizens will provide an input to the planning of future activities and to possible calls for proposals for the distribution of the 80 million euro for funding science and society actions under the EU's Sixth Framework Programme (2002-2006). Science and society is a new theme in Community research, but the debate on the need for this has been going Academy of Finland releases new guide to applicants for research funding The Academy of Finland has released its 2003 Guide for Applicants. There have been no major changes in application procedures. More Research Ethics Current Events and Research Ethics News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||